In his greenhouse at the Cold SpringHarbor Laboratory in Long Island, N.Y., plant geneticist Zach Lippman is growing cherry tomatoes.
But they don't look like the ones that most people grow in their gardens and greenhouses.
Lippman's tomatoes have shorter stemsand the fruit is more tightly clustered, looking more like grapes.
"With gene editing, we now have the ability to fine-tune at will," he said. "So instead of having black or white, small fruit [or] big fruit, you can have everything in between."
Lippman used CRISPR arevolutionarygene-editing tool that can quickly and precisely edit DNA to tweak three of the plant's genes, and make them suitable for large-scale urban agriculture for the first time.
With CRISPR, researchers can precisely target and cut any kind of genetic material. Don't want your mushrooms to turn brown after a few days? Remove the gene that causes thatand problem solved.
There's a lot of excitement about the introduction of gene-edited products into the Canadian food system over the next few years, but a lot of trepidation as well.
The food industry's last foray into genetic engineering genetically modified organisms (GMOs) in the 1990s was a financial success. But the practice is an ongoing public relations nightmare, as many Canadians remain wary of products critics have labelled "Frankenfoods."
Currently, the only gene-edited product commercially available is a soybean oil being used by a restaurant chain in the American Midwest for cooking and salad dressings. It has a longer shelf life than other cooking oils and produces less saturated fat and no trans fat.
Ian Affleck, vice-president of plant biotechnology at CropLife Canada, a trade association that represents Canadian manufacturers of pesticides and plant-breeding products, estimates the soybean oil might be in Canada in a year or two, followed by some altered fruits and vegetables.
Even then, he said, supplies will likely be limited while farmers and food companies determine if consumers will embrace genetically edited food.
All the major health organizations in the world, including Health Canada, have concluded that eating GMO foods does not pose eithershort or long-term health risks.
According to the World Health Organization, GMO goods currently approved for the market "have passed safety assessments and are not likely to present risks for human health."
But Canadians remain stubbornly unconvinced even though about 90 per cent of the corn, soybeansand canola grown in Canada is genetically modified, as is almost all of the processed food we consume.
A 2018 pollby market research company Statista found only 37 per cent of people surveyed strongly or somewhat strongly agreed that GMOs were safe to eat, while 34 per cent strongly or somewhat strongly disagreed.
Industry representatives now say they spent too much time marketing their GMOproducts to farmersand not enough time communicating the benefitsto consumers.
"We spoke to two per cent of the population, who are those who farm," said Affleck. "And those who opposed the technology spoke to the other 98 per cent of the population."
"We thought it was just another transition in plant breeding," recalled Stuart Smyth, who holds the University of Saskatchewan's industry-funded research chair in agri-food innovation. "Nobody expected the environmental groups to develop into a political opposition."
With gene-edited foods, Smyth believes the industry needs to focus on public education to counteract what he calls the "propaganda" that will be coming from the other side.
Gene-edited foods will differ from GMOs in one important respect.
When foods are genetically modified, foreign genes are often added to an existing genome. If you want a vegetable to grow better in cold weather, you could add a gene from a fish that lives in icy water.That's what earned GMO products the "Frankenfoods" moniker.
With gene-editing tools like CRISPR, genes can be cut out, or "turned off," but nothing new is added to the genome.
Lucy Sharratt, co-ordinator of the Canadian Biotechnology Action Network, isn't convinced there's a significant difference.
"The new techniques of gene editing are clearly techniques of genetic engineering," she said. "They are all invasive methods of changing a genome directly at the molecular level.
"While we can produce organisms with new traits, that doesn't mean we know exactly all of what we've done to that organism. There can be many unintended effects," Sharratt further argued.
Unlike GMOs, which require extensive regulatory approval before going to market, gene-edited foods will likely appear without undergoing a risk assessment by Canadian regulators.
Health Canada doesn't require safety testing for new products if it determines those products aren't introducing "novel traits" into the food system. Since it considers gene editing to be an extension of traditional plant breeding, no stamp of approval will be necessary.
That concerns Jennifer Kuzma, co-director of the Genetic Engineering and Society Center at North Carolina State University, whothinks gene-edited products should be tracked and monitored "for those low-level health effects that some products might be contributing to."
Sharratt is also skeptical that gene editing will produce the benefits its supporters claim, pointing to "a biotech industry that has oversold technology and made all kinds of broad promises for the use of genetic engineering that didn't come to pass." Things like reduced pesticide use and greater drought resistance, for example.
Kuzma agrees that GMO researchers have sometimes been guilty of "perhaps overstating the promise of the technology and understating potential risk."But she believes those involved in developing gene-editing techniques want to avoid repeating the mistakes of the past.
"They have a really sincere desire to be more open and transparent in the ways that they communicate and in the sharing of information," she said. "They do realize that the first generation of genetic engineering did not go so well from a public confidence perspective."
The GMO food industry has fiercely opposed one of the most obvious methods to boost public confidence: mandatory labelling, even as a 2018 survey from Dalhousie University showed an overwhelming majority of Canadians support it.
Sixty-four countries require mandatory labelling for GMO products. Canada is not one of them.
There are no plans to require mandatory labelling of gene-edited foods, either.
Jonathan Latham, executive director of the Bioscience Resource Project, a New York-based non-profit organization that researches genetic engineering, thinks that's a mistake.
"If you want people to make informed decisions and you want them to make that in a democratic fashion, then the more information you give them, the better," he said. "And so to deny people information about the content of their food is to violate a very basic democratic right."
Lathamalso believes that not labelling genetically engineered productsincreases consumer skepticism.
"[Consumers] don't really understand why, if a company wants to produce a product and advertise it and tell everybody how good it is, why they shouldn't also want to label it," he said.
Sharratt would like to see Canada adopt the approach taken by the European Court of Justice, which ruled in 2018 that gene-edited foods must undergo the same testing as GMOs before being allowed on grocery store shelves.
Lippman doesn't believe that will happen. In fact, he thinks the potential of gene-edited foods is so great that the public will demand even greater access to suchproducts.
"People will start to be educated and see that there's nothing harmful about it. It's completely fine. And then the only issue sticking out there will be whether we're over-promising.That'll be it."
Click 'listen' above to hear Ira Basen's documentary, The Splice of Life.
Read the original here:
Gene editing could revolutionize the food industry, but it'll have to fight the PR war GMO foods lost - CBC.ca
- What's Going On With Liver Disease Focused Vir Biotechnology Stock Is Friday? - Yahoo Finance - November 16th, 2024
- Department of Biotechnology Launches Webinar Series on Biomanufacturing and Biofoundry Initiative - IBG NEWS - November 16th, 2024
- Multimodal scanning of genetic variants with base and prime editing - Nature.com - November 16th, 2024
- NEW INITIATIVE BY THE ITALIAN EMBASSY IN WASHINGTON ON BIOTECHNOLOGY WITH THE MILKEN INSTITUTE AND LEADING RESEARCHERS AND INDUSTRY EXPERTS -... - November 16th, 2024
- Vir Biotechnology Announces Positive End-of-Treatment Results for Tobevibart and Elebsiran Combinations in Chronic Hepatitis B from the MARCH Study at... - November 16th, 2024
- Albany State offers new Master of Science in Integrated Biotechnology program - The Albany Herald - November 16th, 2024
- What's Going On With Liver Disease Focused Vir Biotechnology Stock Is Friday? - Benzinga - November 16th, 2024
- iNtRON Biotechnology (KOSDAQ:048530) Is In A Strong Position To Grow Its Business - Simply Wall St - November 16th, 2024
- PDS Biotechnology Highlights Clinical Progress and Q3 Results - TipRanks - November 16th, 2024
- We Think Puma Biotechnology's (NASDAQ:PBYI) Robust Earnings Are Conservative - Yahoo Finance - November 16th, 2024
- Puma Biotechnology's (NASDAQ:PBYI) Performance Is Even Better Than Its Earnings Suggest - Simply Wall St - November 16th, 2024
- APHIS Announces Final Notice on Additional Exemptions for the Movement of Organisms Modified or Produced Through Genetic Engineering - USDA APHIS - November 16th, 2024
- Adaptimmune nears second approval for TCR-T therapy - European Biotechnology News - November 16th, 2024
- Lundbeck reports 18% revenue growth in third quarter - The Pharma Letter - November 16th, 2024
- BioNTech to boost oncology offering with buy of Biotheus - The Pharma Letter - November 16th, 2024
- Puma Biotechnology Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance - November 16th, 2024
- WPI Receives Federal Funding to Address Anticipated Demand for Biology and Biotechnology Professionals and Educators - WPI News - November 3rd, 2024
- Jonathan Dinman to Direct the Institute for Bioscience and Biotechnology Research - College of Computer, Mathematical, and Natural Sciences - November 3rd, 2024
- PDS Biotechnology Co. (NASDAQ:PDSB) Given Average Recommendation of "Buy" by Analysts - MarketBeat - November 3rd, 2024
- COP16, DSI mechanism for benefit sharing from the use of digital sequence information approved - Renewable Matter - November 3rd, 2024
- Artificial Intelligence in Biotechnology Market to Hit USD 7.75 Billion by 2029 with 19.1% CAGR | MarketsandMarkets - PR Newswire - November 3rd, 2024
- Axonis Therapeutics raises $115 million in Series A financing - The Pharma Letter - November 3rd, 2024
- Regeneron third-quarter 2024 earnings top expectations - The Pharma Letter - November 3rd, 2024
- AbbVie inks up to $1.4 billion deal with EvolveImmune - The Pharma Letter - November 3rd, 2024
- CEO and Chairman of the Executive Board - European Biotechnology News - November 3rd, 2024
- The transformative potential of biotechnology and AI in healthcare - The Armchair Trader - November 3rd, 2024
- U.S. Biotechnology And Pharmaceutical Services Outsourcing Market Size to Reach USD 16.68 Billion By 2033 - BioSpace - October 6th, 2024
- Vir Biotechnology, Inc. (NASDAQ:VIR) is largely controlled by institutional shareholders who own 53% of the company - Yahoo Finance - October 6th, 2024
- Resolution Therapeutics scores 63.5 million in series B round - The Pharma Letter - October 6th, 2024
- Wiregrass Institute for Biotechnology welcomes local military veteran from Southeast Health as its first computational biologist - AOL - October 6th, 2024
- Generating and characterizing a comprehensive panel of CHO cells glycosylation mutants for advancing glycobiology and biotechnology research -... - October 6th, 2024
- Sapience Therapeutics Announces Participation at the 4th Annual Needham Private Biotech Company Virtual 1x1 Forum - PR Newswire - October 6th, 2024
- Spyre Therapeutics lures Abivax exec to be its CMO - The Pharma Letter - October 6th, 2024
- Convergence is AIxBio: AI and the Bioeconomy - OODA Loop - October 6th, 2024
- Congress targets Chinese influence in health tech. It could come with tradeoffs - ABC News - September 13th, 2024
- Researchers, media engage to educate farmers on biotechnology - University World News - September 13th, 2024
- Congress targets Chinese influence in health tech. It could come with tradeoffs - The Associated Press - September 13th, 2024
- Comer Delivers Remarks in Support of Bipartisan BIOSECURE Act - House Committee on Oversight and Reform | - September 13th, 2024
- Announcement of $2 Million for the University of Delaware to Advance Biotechnology - WGMD Radio - September 13th, 2024
- Thailand's Competitiveness Enhanced Through Advanced Biotechnology at Thailand LAB INTERNATIONAL 2024 - BSA bureau - September 13th, 2024
- Biotechnology company Amgen expands global reach with technology innovation center in Hyderabad, India - BioProcess Insider - September 13th, 2024
- Adam's Biotech Scorecard: Can iTeos and GSK solve TIGIT's troubles? - STAT - September 13th, 2024
- Cizzle Biotechnology Advancing Lung Cancer Detection from R&D to Application with Moffitt Cancer Centre (VIDEO) - DirectorsTalk Interviews - September 13th, 2024
- MAIA Biotechnology Announces Positive Survival Updates in Phase 2 Study of THIO in Non-Small Cell Lung Cancer - Business Wire - September 13th, 2024
- MAIA Biotechnology Advances with Clinical Trials and Partnerships - TipRanks - September 13th, 2024
- Viridian Therapeutics reports positive results for veligrotug - The Pharma Letter - September 13th, 2024
- Chinese biotech firms refute US bill, stressing they have no access to Americans personal data - Global Times - September 13th, 2024
- Vir Biotechnology Enhances Portfolio with Sanofi Deal and Executive Appointments - TipRanks - September 13th, 2024
- Tesla BioHealing and Cell Biotechnology Partner to Advance Stem Cell Therapies - Vancity Buzz - September 13th, 2024
- Time to leverage intellectual property to drive innovation in seed and biotechnology sectors: Experts - The Times of India - May 5th, 2024
- Where Does Capricor Therapeutics Inc (CAPR) Stock Fall in the Biotechnology Field After It Has Risen 24.73% This Week? - InvestorsObserver - March 10th, 2024
- Where Does SpringWorks Therapeutics Inc (SWTX) Stock Fall in the Biotechnology Field After It Has Gained 12.41% This Week? - InvestorsObserver - February 18th, 2024
- Should Biotechnology Stock Axsome Therapeutics Inc (AXSM) Be in Your Portfolio Wednesday? - InvestorsObserver - February 18th, 2024
- Where Does Candel Therapeutics Inc (CADL) Stock Fall in the Biotechnology Field After It Has Gained 22.38% This Week? - InvestorsObserver - February 18th, 2024
- What is Biotechnology? Types and Applications - Iberdrola - January 25th, 2024
- Where Does Immunitybio Inc (IBRX) Stock Fall in the Biotechnology Field After It Is Lower By -9.32% This Week? - InvestorsObserver - January 25th, 2024
- Can Sana Biotechnology Inc (SANA) Stock Rise to the Top of Healthcare Sector Monday? - InvestorsObserver - January 25th, 2024
- Should You Buy Sana Biotechnology Inc (SANA) Stock After it Has Fallen 15.41% in a Week? - InvestorsObserver - January 25th, 2024
- Where Does Tscan Therapeutics Inc (TCRX) Stock Fall in the Biotechnology Field After It Is Lower By -9.81% This Week? - InvestorsObserver - January 25th, 2024
- Should Biotechnology Stock Mink Therapeutics Inc (INKT) Be in Your Portfolio Monday? - InvestorsObserver - May 9th, 2023
- Where Does Ambrx Biopharma Inc - ADR (AMAM) Stock Fall in the Biotechnology Field After It Has Risen 22.18% This Week? - InvestorsObserver - May 9th, 2023
- Should Biotechnology Stock Dermata Therapeutics Inc (DRMA) Be in Your Portfolio Thursday? - InvestorsObserver - May 9th, 2023
- Should Biotechnology Stock Tempest Therapeutics Inc (TPST) Be in Your Portfolio Wednesday? - InvestorsObserver - May 9th, 2023
- Biotechnology - Applications of biotechnology | Britannica - May 1st, 2023
- Where Does BioLine RX Ltd - ADR (BLRX) Stock Fall in the Biotechnology Field After It Is Down -3.67% This Week? - InvestorsObserver - May 1st, 2023
- Where Does Apellis Pharmaceuticals Inc (APLS) Stock Fall in the Biotechnology Field After It Is Higher By 4.17% This Week? - InvestorsObserver - May 1st, 2023
- Where Does Aldeyra Therapeutics Inc (ALDX) Stock Fall in the Biotechnology Field After It Is Lower By -11.45% This Week? - InvestorsObserver - May 1st, 2023
- Is Rain Oncology Inc (RAIN) Stock at the Top of the Biotechnology Industry? - InvestorsObserver - April 7th, 2023
- Does Sana Biotechnology Inc (SANA) Have What it Takes to be in Your Portfolio Tuesday? - InvestorsObserver - April 7th, 2023
- Where Does Ambrx Biopharma Inc - ADR (AMAM) Stock Fall in the Biotechnology Field After It Is Lower By -15.43% This Week? - InvestorsObserver - April 7th, 2023
- Where Does Protagonist Therapeutics Inc (PTGX) Stock Fall in the Biotechnology Field After It Has Risen 3.62% This Week? - InvestorsObserver - April 7th, 2023
- What is Biotechnology? Definition, Types and Applications | TechTarget - March 21st, 2023
- Where Does Novavax Inc (NVAX) Stock Fall in the Biotechnology Field After It Is Lower By -12.99% This Week? - InvestorsObserver - March 21st, 2023
- Should Biotechnology Stock Outlook Therapeutics Inc (OTLK) Be in Your Portfolio Thursday? - InvestorsObserver - March 21st, 2023
- SANA BIOTECHNOLOGY, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K) - Marketscreener.com - March 21st, 2023
- Where Does Revance Therapeutics Inc (RVNC) Stock Fall in the Biotechnology Field After It Is Lower By -2.17% This Week? - InvestorsObserver - March 5th, 2023
- Is TG Therapeutics Inc common stock (TGTX) Stock at the Top of the Biotechnology Industry? - InvestorsObserver - March 5th, 2023
- Where Does GT Biopharma Inc (GTBP) Stock Fall in the Biotechnology Field After It Is Down -20.73% This Week? - InvestorsObserver - March 5th, 2023
- Where Does Dyne Therapeutics Inc (DYN) Stock Fall in the Biotechnology Field After It Is Lower By -2.35% This Week? - InvestorsObserver - March 5th, 2023
- Is CytomX Therapeutics Inc (CTMX) Stock at the Top of the Biotechnology Industry? - InvestorsObserver - November 17th, 2022